Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience

por Lasa-Lázaro, María, Ramos-Boluda, Esther, Mancebo, Esther, Castro-Panete, María José, González-Sacristán, Rocío, Serradilla, Javier, Andrés-Moreno, Ane Miren, Hernández-Oliveros, Francisco, Paz-Artal, Estela, Talayero, Paloma
Publicado 2023

IL-6–based mortality risk model for hospitalized patients with COVID-19

por Laguna-Goya, Rocio, Utrero-Rico, Alberto, Talayero, Paloma, Lasa-Lazaro, Maria, Ramirez-Fernandez, Angel, Naranjo, Laura, Segura-Tudela, Alejandro, Cabrera-Marante, Oscar, Rodriguez de Frias, Edgar, Garcia-Garcia, Rocio, Fernández-Ruiz, Mario, Aguado, Jose Maria, Martinez-Lopez, Joaquin, Lopez, Elena Ana, Catalan, Mercedes, Serrano, Antonio, Paz-Artal, Estela
Publicado 2020